Open-Label Extension Study to Pioneer Study 6058-SCD-101

Clinical trial NCT07401823 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07401823
Sponsor: Fulcrum Therapeutics
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2026-03-30
Primary completion: 2030-02-04
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.